Drug Search Results
More Filters [+]

Denatonium benzoate

Alternative Names: denatonium benzoate, aversion
Latest Update: 2024-08-25
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Chile | Pakistan

Approved Indications: None

Known Adverse Events: None

Company: Universitaire Ziekenhuizen KU Leuven
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Denatonium benzoate

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ChiCTR2300071590

N/A

Not yet recruiting

Alcoholism

2025-06-30

Pro00111134

N/A

Completed

Spinal Dysraphism|Urinary Bladder, Neurogenic

2024-04-18

ACTRN12620001193965

N/A

Recruiting

COVID-19

2020-11-30

DRAC

N/A

Withdrawn

Multiple Sclerosis

2019-03-01

Recent News Events